Evidence map›Paper›PMID 18843039›Full record

ArticleMolecular biology of the cell2008

The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis.

Peter A Keyel, James R Thieman, Robyn Roth, Elif Erkan, Eric T Everett, Simon C Watkins, John E Heuser, Linton M Traub

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Autophagy initiation triggers p150Cellular and molecular life sciences : CMLS · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Endocytic receptor LRP2/megalin-of holoprosencephaly and renal Fanconi syndrome.Pflugers Archiv : European journal of physiology · 2017
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Coxiella burnetii effector protein subverts clathrin-mediated vesicular trafficking for pathogen vacuole biogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  20. Cargo recognition in clathrin-mediated endocytosis.Cold Spring Harbor perspectives in biology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Peter A KeyelDepartment of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
James R Thieman
Robyn Roth
Elif Erkan
Eric T Everett
Simon C Watkins
John E Heuser
Linton M Traub
University of Pittsburgh · USWashington University in St. Louis · USUniversity of North Carolina at Chapel Hill · US

Funding

CLATHRIN COATED VESICLES AND LYSOSOME FUNCTIONR01DK053249 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TRAUB, LINTON M. · 1998 to 2011
$3.0M
Non-Syndromic Cleft Palate in MiceR21DE015180 · NIDCR · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI EVERETT, ERIC T. · 2003 to 2004
$376k
NIDCR NIH HHS DE015180NIDCR NIH HHS R21 DE015180NIDDK NIH HHS R01 DK053249NIDDK NIH HHS R01 DK53249
6 · The paper itself

Abstract

The independently folded appendages of the large alpha and beta2 subunits of the endocytic adaptor protein (AP)-2 complex coordinate proper assembly and operation of endocytic components during clathrin-mediated endocytosis. The beta2 subunit appendage contains a common binding site for beta-arrestin or the autosomal recessive hypercholesterolemia (ARH) protein. To determine the importance of this interaction surface in living cells, we used small interfering RNA-based gene silencing. The effect of extinguishing beta2 subunit expression on the internalization of transferrin is considerably weaker than an AP-2 alpha subunit knockdown. We show the mild sorting defect is due to fortuitous substitution of the beta2 chain with the closely related endogenous beta1 subunit of the AP-1 adaptor complex. Simultaneous silencing of both beta1 and beta2 subunit transcripts recapitulates the strong alpha subunit RNA interference (RNAi) phenotype and results in loss of ARH from endocytic clathrin coats. An RNAi-insensitive beta2-yellow fluorescent protein (YFP) expressed in the beta1 + beta2-silenced background restores cellular AP-2 levels, robust transferrin internalization, and ARH colocalization with cell surface clathrin. The importance of the beta appendage platform subdomain over clathrin for precise deposition of ARH at clathrin assembly zones is revealed by a beta2-YFP with a disrupted ARH binding interface, which does not restore ARH colocalization with clathrin. We also show a beta-arrestin 1 mutant, which engages coated structures in the absence of any G protein-coupled receptor stimulation, colocalizes with beta2-YFP and clathrin even in the absence of an operational clathrin binding sequence. These findings argue against ARH and beta-arrestin binding to a site upon the beta2 appendage platform that is later obstructed by polymerized clathrin. We conclude that ARH and beta-arrestin depend on a privileged beta2 appendage site for proper cargo recruitment to clathrin bud sites.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsArrestinsbeta-Arrestin 1beta-ArrestinsCell LineClathrinEndocytosisGene SilencingHumansMiceMice, KnockoutProtein SubunitsProtein TransportReceptor, Angiotensin, Type 1Recombinant Fusion ProteinsAdaptor Proteins, Signal TransducingARRB1 protein, humanArrb1 protein, mouseArrestinsbeta-Arrestin 1beta-ArrestinsClathrinLDLRAP1 protein, humanProtein SubunitsReceptor, Angiotensin, Type 1Recombinant Fusion ProteinsRNA, Small InterferingTranscription Factor AP-2Transferrin

Identifiers

PMID18843039
PMCPMC2592659
OpenAlexW2113753551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.